β-blockers to optimize peripheral oxygenation during extracorporeal membrane oxygenation: A case series

Fabio Guarracino, Alberto Zangrillo, Laura Ruggeri, Marina Pieri, Maria Grazia Calabrò, Giovanni Landoni, Maurizio Stefani, Luca Doroni, Federico Pappalardo

Research output: Contribution to journalArticle

Abstract

Objectives: Veno-venous extracorporeal membrane oxygenation (ECMO) is a well-established therapy in patients affected by respiratory failure and unresponsive to conventional therapy. Despite technical innovations, some limitations still exist, the most important one being refractory hypoxemia. This problem is linked partially to the mixture between patients' blood and ECMO fully oxygenated blood. In the present work, the reduction of cardiac output was proposed for the treatment of refractory hypoxemia in patients with high-flow ECMO and high endogenous cardiac output. Design: An observational study. Setting: A university hospital. Participants: Three consecutive patients suffering from persisting severe hypoxemia despite high-flow ECMO and with concomitant high cardiac output (>7 L/min). Intervention: A bolus dose of 500 μg/kg and a continuous infusion of esmolol was used and titrated to an SpO 2 >92%. Measurements and Main Results: Esmolol administration was safe and highly beneficial in terms of peripheral oxygenation. PaO 2 increased from 54 to 90 mmHg, from 50 to 94 mmHg, and from 49 to 66 mmHg during the first 12 hours of esmolol treatment in the 3 patients. Conclusions: In selected septic, tachycardic patients with a high cardiac output, veno-venous ECMO, led to improvement of peripheral oxygenation with the addition of a short-acting β-blocker infusion.

Original languageEnglish
Pages (from-to)58-63
Number of pages6
JournalJournal of Cardiothoracic and Vascular Anesthesia
Volume26
Issue number1
DOIs
Publication statusPublished - Feb 2012

Fingerprint

Extracorporeal Membrane Oxygenation
High Cardiac Output
Therapeutics
Respiratory Insufficiency
Cardiac Output
Observational Studies
Hypoxia
esmolol

Keywords

  • β-blockers
  • acute respiratory distress syndrome (ARDS)
  • anesthesia
  • esmolol
  • extracorporeal membrane oxygenation (ECMO)
  • intensive care
  • refractory hypoxemia

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Anesthesiology and Pain Medicine

Cite this

β-blockers to optimize peripheral oxygenation during extracorporeal membrane oxygenation : A case series. / Guarracino, Fabio; Zangrillo, Alberto; Ruggeri, Laura; Pieri, Marina; Calabrò, Maria Grazia; Landoni, Giovanni; Stefani, Maurizio; Doroni, Luca; Pappalardo, Federico.

In: Journal of Cardiothoracic and Vascular Anesthesia, Vol. 26, No. 1, 02.2012, p. 58-63.

Research output: Contribution to journalArticle

Guarracino, Fabio ; Zangrillo, Alberto ; Ruggeri, Laura ; Pieri, Marina ; Calabrò, Maria Grazia ; Landoni, Giovanni ; Stefani, Maurizio ; Doroni, Luca ; Pappalardo, Federico. / β-blockers to optimize peripheral oxygenation during extracorporeal membrane oxygenation : A case series. In: Journal of Cardiothoracic and Vascular Anesthesia. 2012 ; Vol. 26, No. 1. pp. 58-63.
@article{dfb105bea80a4ef4a2b18c13fb303916,
title = "β-blockers to optimize peripheral oxygenation during extracorporeal membrane oxygenation: A case series",
abstract = "Objectives: Veno-venous extracorporeal membrane oxygenation (ECMO) is a well-established therapy in patients affected by respiratory failure and unresponsive to conventional therapy. Despite technical innovations, some limitations still exist, the most important one being refractory hypoxemia. This problem is linked partially to the mixture between patients' blood and ECMO fully oxygenated blood. In the present work, the reduction of cardiac output was proposed for the treatment of refractory hypoxemia in patients with high-flow ECMO and high endogenous cardiac output. Design: An observational study. Setting: A university hospital. Participants: Three consecutive patients suffering from persisting severe hypoxemia despite high-flow ECMO and with concomitant high cardiac output (>7 L/min). Intervention: A bolus dose of 500 μg/kg and a continuous infusion of esmolol was used and titrated to an SpO 2 >92{\%}. Measurements and Main Results: Esmolol administration was safe and highly beneficial in terms of peripheral oxygenation. PaO 2 increased from 54 to 90 mmHg, from 50 to 94 mmHg, and from 49 to 66 mmHg during the first 12 hours of esmolol treatment in the 3 patients. Conclusions: In selected septic, tachycardic patients with a high cardiac output, veno-venous ECMO, led to improvement of peripheral oxygenation with the addition of a short-acting β-blocker infusion.",
keywords = "β-blockers, acute respiratory distress syndrome (ARDS), anesthesia, esmolol, extracorporeal membrane oxygenation (ECMO), intensive care, refractory hypoxemia",
author = "Fabio Guarracino and Alberto Zangrillo and Laura Ruggeri and Marina Pieri and Calabr{\`o}, {Maria Grazia} and Giovanni Landoni and Maurizio Stefani and Luca Doroni and Federico Pappalardo",
year = "2012",
month = "2",
doi = "10.1053/j.jvca.2011.05.013",
language = "English",
volume = "26",
pages = "58--63",
journal = "Journal of Cardiothoracic and Vascular Anesthesia",
issn = "1053-0770",
publisher = "W B SAUNDERS CO-ELSEVIER INC",
number = "1",

}

TY - JOUR

T1 - β-blockers to optimize peripheral oxygenation during extracorporeal membrane oxygenation

T2 - A case series

AU - Guarracino, Fabio

AU - Zangrillo, Alberto

AU - Ruggeri, Laura

AU - Pieri, Marina

AU - Calabrò, Maria Grazia

AU - Landoni, Giovanni

AU - Stefani, Maurizio

AU - Doroni, Luca

AU - Pappalardo, Federico

PY - 2012/2

Y1 - 2012/2

N2 - Objectives: Veno-venous extracorporeal membrane oxygenation (ECMO) is a well-established therapy in patients affected by respiratory failure and unresponsive to conventional therapy. Despite technical innovations, some limitations still exist, the most important one being refractory hypoxemia. This problem is linked partially to the mixture between patients' blood and ECMO fully oxygenated blood. In the present work, the reduction of cardiac output was proposed for the treatment of refractory hypoxemia in patients with high-flow ECMO and high endogenous cardiac output. Design: An observational study. Setting: A university hospital. Participants: Three consecutive patients suffering from persisting severe hypoxemia despite high-flow ECMO and with concomitant high cardiac output (>7 L/min). Intervention: A bolus dose of 500 μg/kg and a continuous infusion of esmolol was used and titrated to an SpO 2 >92%. Measurements and Main Results: Esmolol administration was safe and highly beneficial in terms of peripheral oxygenation. PaO 2 increased from 54 to 90 mmHg, from 50 to 94 mmHg, and from 49 to 66 mmHg during the first 12 hours of esmolol treatment in the 3 patients. Conclusions: In selected septic, tachycardic patients with a high cardiac output, veno-venous ECMO, led to improvement of peripheral oxygenation with the addition of a short-acting β-blocker infusion.

AB - Objectives: Veno-venous extracorporeal membrane oxygenation (ECMO) is a well-established therapy in patients affected by respiratory failure and unresponsive to conventional therapy. Despite technical innovations, some limitations still exist, the most important one being refractory hypoxemia. This problem is linked partially to the mixture between patients' blood and ECMO fully oxygenated blood. In the present work, the reduction of cardiac output was proposed for the treatment of refractory hypoxemia in patients with high-flow ECMO and high endogenous cardiac output. Design: An observational study. Setting: A university hospital. Participants: Three consecutive patients suffering from persisting severe hypoxemia despite high-flow ECMO and with concomitant high cardiac output (>7 L/min). Intervention: A bolus dose of 500 μg/kg and a continuous infusion of esmolol was used and titrated to an SpO 2 >92%. Measurements and Main Results: Esmolol administration was safe and highly beneficial in terms of peripheral oxygenation. PaO 2 increased from 54 to 90 mmHg, from 50 to 94 mmHg, and from 49 to 66 mmHg during the first 12 hours of esmolol treatment in the 3 patients. Conclusions: In selected septic, tachycardic patients with a high cardiac output, veno-venous ECMO, led to improvement of peripheral oxygenation with the addition of a short-acting β-blocker infusion.

KW - β-blockers

KW - acute respiratory distress syndrome (ARDS)

KW - anesthesia

KW - esmolol

KW - extracorporeal membrane oxygenation (ECMO)

KW - intensive care

KW - refractory hypoxemia

UR - http://www.scopus.com/inward/record.url?scp=84855315083&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855315083&partnerID=8YFLogxK

U2 - 10.1053/j.jvca.2011.05.013

DO - 10.1053/j.jvca.2011.05.013

M3 - Article

C2 - 21764329

AN - SCOPUS:84855315083

VL - 26

SP - 58

EP - 63

JO - Journal of Cardiothoracic and Vascular Anesthesia

JF - Journal of Cardiothoracic and Vascular Anesthesia

SN - 1053-0770

IS - 1

ER -